S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:STAA

STAAR Surgical Stock Forecast, Price & News

$97.18
-6.43 (-6.21%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$96.18
$104.70
50-Day Range
$97.18
$147.36
52-Week Range
$69.00
$163.08
Volume
258,051 shs
Average Volume
501,669 shs
Market Capitalization
$4.63 billion
P/E Ratio
211.27
Dividend Yield
N/A
Beta
0.95
30 days | 90 days | 365 days | Advanced Chart
Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.


STAAR Surgical logo

About STAAR Surgical

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Headlines

CEO Of Staar Surgical Trades $12M In Company Stock
November 19, 2021 |  finance.yahoo.com
Contrasting Warby Parker (NYSE:WRBY) & STAAR Surgical (NASDAQ:STAA)
November 19, 2021 |  americanbankingnews.com
STAAR Surgical (NASDAQ:STAA) CEO Sells $3,997,000.00 in Stock
November 18, 2021 |  americanbankingnews.com
Reviewing STAAR Surgical (NASDAQ:STAA) & Warby Parker (NYSE:WRBY)
November 2, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:STAA
CUSIP
85231230
Employees
575
Year Founded
1982

Sales & Book Value

Annual Sales
$163.46 million
Cash Flow
$0.37 per share
Book Value
$5.23 per share

Profitability

Net Income
$5.91 million
Pretax Margin
13.39%

Debt

Price-To-Earnings

Miscellaneous

Free Float
45,886,000
Market Cap
$4.63 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/03/2021
Today
11/27/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/23/2022

Social Links


MarketRank

Overall MarketRank

2.30 out of 5 stars

Medical Sector

281st out of 1,391 stocks

Ophthalmic Goods Industry

2nd out of 5 stocks

Analyst Opinion: 3.1Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -












STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

Is STAAR Surgical a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" STAAR Surgical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View analyst ratings for STAAR Surgical
or view top-rated stocks.

How has STAAR Surgical's stock been impacted by Coronavirus?

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, STAA shares have increased by 246.9% and is now trading at $97.18.
View which stocks have been most impacted by COVID-19
.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for STAAR Surgical
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) posted its earnings results on Wednesday, November, 3rd. The medical instruments supplier reported $0.12 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.11 by $0.01. The medical instruments supplier earned $58.35 million during the quarter, compared to analysts' expectations of $57.70 million. STAAR Surgical had a net margin of 10.53% and a trailing twelve-month return on equity of 13.06%. During the same period in the previous year, the company earned $0.14 earnings per share.
View STAAR Surgical's earnings history
.

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical updated its FY 2021 earnings guidance on Wednesday, November, 17th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $230 million-$231 million, compared to the consensus revenue estimate of $229.17 million.

What price target have analysts set for STAA?

4 equities research analysts have issued 1-year target prices for STAAR Surgical's shares. Their forecasts range from $150.00 to $150.00. On average, they anticipate STAAR Surgical's share price to reach $150.00 in the next year. This suggests a possible upside of 54.4% from the stock's current price.
View analysts' price targets for STAAR Surgical
or view top-rated stocks among Wall Street analysts.

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical CEO Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among STAAR Surgical's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by many different retail and institutional investors. Top institutional investors include Broadwood Capital Inc. (18.20%), BlackRock Inc. (11.62%), Baillie Gifford & Co. (11.53%), Ensign Peak Advisors Inc (1.79%), Geode Capital Management LLC (1.74%) and Geneva Capital Management LLC (1.46%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends for STAAR Surgical
.

Which major investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Morgan Stanley, Geneva Capital Management LLC, Baillie Gifford & Co., Goldman Sachs Group Inc., TCW Group Inc., Millennium Management LLC, and RE Advisers Corp. Company insiders that have sold STAAR Surgical company stock in the last year include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams, and Samuel J Gesten.
View insider buying and selling activity for STAAR Surgical
or view top insider-selling stocks.

Which major investors are buying STAAR Surgical stock?

STAA stock was purchased by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Pura Vida Investments LLC, E Fund Management Co. Ltd., Aegon Asset Management UK PLC, Citigroup Inc., Dimensional Fund Advisors LP, BlackRock Inc., and Two Sigma Advisers LP.
View insider buying and selling activity for STAAR Surgical
or or view top insider-buying stocks.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $97.18.

How much money does STAAR Surgical make?

STAAR Surgical has a market capitalization of $4.63 billion and generates $163.46 million in revenue each year. The medical instruments supplier earns $5.91 million in net income (profit) each year or $0.46 on an earnings per share basis.

How many employees does STAAR Surgical have?

STAAR Surgical employs 575 workers across the globe.

Does STAAR Surgical have any subsidiaries?

The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

When was STAAR Surgical founded?

STAAR Surgical was founded in 1982.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

Where are STAAR Surgical's headquarters?

STAAR Surgical is headquartered at 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at [email protected], or via fax at 626-303-2962.


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.